Daxor Corporation Announces Appointment Of Dr. Donald Margouleff To Director Of Nuclear Medicine

NEW YORK--(BUSINESS WIRE)--Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, announces that Dr. Donald Margouleff, an expert in the field of Nuclear Medicine, has joined its staff as Daxor’s Director of Nuclear Medicine. Nuclear Medicine consulting services will be offered to the medical industry under his direction.
MORE ON THIS TOPIC